REVIVA PHARMACEUTCLS HLDGS I's ticker is and the CUSIP is 76152G900. A total of 4 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208 | +19.5% | 42,800 | +43.6% | 0.00% | – |
| Q2 2023 | $174 | -25.0% | 29,800 | -46.3% | 0.00% | – |
| Q1 2023 | $232 | +648.4% | 55,500 | +660.3% | 0.00% | – |
| Q4 2022 | $31 | -99.9% | 7,300 | -67.7% | 0.00% | – |
| Q3 2022 | $35,000 | +6.1% | 22,600 | -26.1% | 0.00% | – |
| Q2 2022 | $33,000 | -56.0% | 30,600 | 0.0% | 0.00% | – |
| Q1 2022 | $75,000 | – | 30,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,099 | $536,312 | 0.39% |
| GROUP ONE TRADING, L.P. | 211,200 | $1,030,656 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 42,800 | $208 | 0.00% |